Hepatocellular Carcinoma Clinical Trials in Ulm
3 recruitingUlm, Germany
Showing 1–3 of 3 trials
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 2
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
ImmunotherapyHCC - Hepatocellular Carcinoma
Michael Dill48 enrolled7 locationsNCT05690048
Recruiting
Phase 3
The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest434 enrolled72 locationsNCT04803994